Gilead Sciences will distribute remdesivir as a coronavirus drug at $2,340 per patient and the U.S. is expected to be the first country to get most of the company's supply.

Remdesivir was authorized conditional marketing by the European Medicines Agency on June 25.

A good thing though is that nutrition experts have come up with dietary supplements to complement this popular diet. Here are some of the best supplements -- from pills, powder to drops -- that can...

A new study finds 125 natural compounds from medicinal plants that can block COVID-19 proteins.

As in the case of many dietary supplements, zinc supplements have health benefits and potential adverse effects that need to be known.

Bristol Myers Squibb, Eli Lilly, Pfizer and other companies saw delays in new clinical trials with life-saving medications for other diseases because of the spread of the novel coronavirus.

Researchers found that the cheap and widely available steroid drug, dexamethasone, could help reduce the risk of dying for patients who are critically ill with COVID-19.

A systematic review by University of Pennsylvania found 115 off-label drugs that could possibly treat COVID-19.

Despite reports that hydroxychloroquine provides little to no effects against COVID-19, some researchers expressed confidence that the drug still has the potential to support prevention of infection. 

A heartburn drug reportedly rendered positive results for people who are dealing with COVID-19.

Mental health is anticipated to be come the next problem with most people facing issues while being confined to their home.

Despite the clear hype surrounding it, research is becoming clear that Gilead Sciences’ remdesivir doesn’t seem of much help to COVID-19 patients.